Product Information
NAFTIFINE HCL 2% GEL is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $8.9536 per GM under NDC 51672137606. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Apr 10, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672137606
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NAFTIFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208201FDA Approved
4/10/2019
TE Code
AB
On Market Since
4/1/2023
Pharmacological Classes
Price Statistics
The NADAC for NAFTIFINE HCL 2% GEL has been published 116 times since Jul 17, 2024, and over the history we have for it it has risen 29.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9536 per GM |
|---|---|
| All-time high | $9.2462 (May 13, 2026) |
| All-time low | $6.9426 (Jul 17, 2024) |
| 52-week high | $9.2462 |
| 52-week low | $7.3670 |
| Median price | $7.4312 |
| Average price | $7.7939 |
| Largest weekly change | +25.5% (Apr 22, 2026) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naftifine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naftifine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Allylamine Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAFTIFINE HCL 2% GEL?
The current National Average Drug Acquisition Cost (NADAC) for NAFTIFINE HCL 2% GEL, manufactured by Sun Pharmaceutical Industries Inc., is $8.9536 per GM (NDC 51672137606), effective Sep 30, 2026.
How has the price of NAFTIFINE HCL 2% GEL changed over time?
Over the history we have for it, the NADAC for NAFTIFINE HCL 2% GEL has risen 29.0%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for NAFTIFINE HCL 2% GEL?
Since Jul 17, 2024, the NADAC for NAFTIFINE HCL 2% GEL has ranged from a low of $6.9426 (Jul 17, 2024) to a high of $9.2462 (May 13, 2026), with a median of $7.4312 per GM.
Are there cheaper alternatives to NAFTIFINE HCL 2% GEL?
No other NADAC-published product currently shares the active ingredient and strength of NAFTIFINE HCL 2% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NAFTIFINE HCL 2% GEL?
NAFTIFINE HCL 2% GEL (NDC 51672137606) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.